Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Pharm-Olam Adds Offices in Latin America | Contract Pharma

What are you searching for?

Sign in
Breaking News

Pharm-Olam Adds Offices in Latin America

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Pharm-Olam International Ltd. is expanding its capabilities in Latin America by opening local offices in São Paulo, Brazil and Buenos Aires, Argentina. The new offices are scheduled to open in September 2006. Dr. Jorge Fiuza, who has more than 15 years of clinical trial management experience in the region, oversees the Latin American operations.

“From our previous experience conducting trials in these countries, we know that these areas offer great opportunities for finding treatment-naive patients, and having local offices there will improve the efficiency of Pharm-Olam’s global trial logistics,” said Iain Gordon, director of global business development. “Pharm-Olam has experience conducting trials throughout Latin America, where we have strong relationships with local physicians and an impressive network of sites, including some of the largest medical centers in the region.”

The company established a local office in Mexico City in 2002, and with the additional offices in São Paulo and Buenos Aires, it now has a local presence in the three most populated areas in Latin America with an estimated combined population of more than 50 million.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics